PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation

International Journal of Artificial Organs

Volumn 28, Issue 8, 2005, Pages 834-840

  Yoshizaki, T ^a   Tabuchi, Noriyuki ^a   Van Oeveren, W ^c   Shibamiya, A ^b   Koyama, T ^b   Sunamori, M ^a  

^a Faculty of Medicine   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

CD11b; Extracorporeal circulation; In vitro model; PMEA; Thrombin

Indexed keywords

BLOOD; DAMAGE DETECTION; POLYSACCHARIDES; POLYVINYL CHLORIDES; TUBING;

ANTI-THROMBOGENICITY; BLOOD CIRCULATION; CD11B; EXTRACORPOREAL CIRCULATION; HAEMOCOMPATIBILITY; IN-VITRO; IN-VITRO MODELS; PMEA; PROPERTY; WHOLE BLOOD;

ENZYMES;

BLOOD CLOTTING FACTOR 12A; CD11B ANTIGEN; COMPLEMENT COMPONENT C3A; FIBRIN; HEPARIN; POLY(2 METHOXYETHYLACRYLATE); POLYACRYLIC ACID; THROMBIN; UNCLASSIFIED DRUG;

ADSORPTION; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL MODEL; BLOOD DONOR; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; HEPARINIZATION; HUMAN; IN VITRO STUDY; LEUKOCYTE; PROTEIN BLOOD LEVEL; VOLUNTEER;

EID: 27544438957     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800809     Document Type: Article

References (17)

1. Schreurs HH, Wijers MJ, Gu YJ, van Oeveren W, van Domburg RT, de Boer JH, Bogers AJ. Heparin-coated bypass circuits: Effects on inflammatory response in pediatric cardiac operations. Ann Thorac Surg 1998; 66: 166-71.
2. Mueller XM, Jegger D, Augstburger M, Horisberger J, von Segesser LK. Poly2-methoxyethylacrylate (PMEA) coated oxygenator: An ex vivo study. Int J Artif Organs 2002; 25: 223-9.
3. Baykut D, Bernet F, Wehrle J, Weichelt K, Schwartz P, Zerkowski HR. New surface biopolymers for oxygenators: An in vitro hemocompatibility test of poly(2-methoxyethylacrylate). Eur J Med Res 2001; 6: 297-305.
4. Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg 2003; 75: 913-8.
5. Tanaka M, Mochizuki A. Effect of water structure on blood compatibility-thermal analysis of water in poly(meth)acrylate. J Biomed Mater Res 2004; 68A: 684-95.
6. Suhara H, Sawa Y, Nishimura M, Oshiyama H, Yokoyama K, Saito N, Matsuda H. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg 2001; 71: 1603-8.
7. de Haan J, Boonstra PW, Tabuchi N, van Oeveren W, Ebels T. Retransfusion of wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit. J Thorac Cardiovasc Surg 1996; 111: 272-5.
8. Mollnes TE, Riesenfeld J, Garred P, Nordstrom E, Hogasen K, Fosse E, Gotze O, Harboe M. A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Int J Artif Organs 1995; 19: 909-17.
9. Van Oeveren W, Haan J, Lagerman P, Schoen P. In vitro testing of coagulation activity of biomaterials. Artif Organs 2002; 26: 506-11.
10. van der Kamp KWHJ, van Oeveren W. B-factor XIIa and kallikrein generation in plasma during incubation with biomaterials. J Biomed Mater Res 1994; 24: 349-52.
11. Fujimori N, Naito H, Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: Evaluation by confocal laser scanning fluorescence microscopy. Artif Organs 1998; 22: 1014-7.
12. Tabuchi N, Shibamiya A, Koyama T, Fukuda T, van Oeveren W, Sunamori M. Activated leukocyte adsorbed on the surface of the extracorporeal circuit. Artif Organs 2003; 27: 591-4.
13. Shibamiya A, Tabuchi N, Chung J, Sunamori M, Koyama T. Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass. Thromb Haemost 2004; 92: 124-31.
14. Sturk-Maquelin KN, Nieuwland R, Romijn FP, Nieuwland R, Romijn FP, Eijsman L, Hack CE, Sturk A. Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo. J Thromb Haemost 2003; 1: 1920-6.
15. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem 2000; 275: 20514-9.
16. Tabuchi N, de Haan J, Boonstra PW, et al. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 828-33.
17. Amoroso G, van Boven AJ, Volkers C, Crijns HJ, van Oeveren W. Multilink stent promotes less platelet and leukocyte adhesion than a traditional stainless steel stent: An in vitro experimental study. J Investig Med 2001; 49: 265-72.